ProShare Advisors’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-66,417
Closed -$14.1M 2012
2014
Q4
$14.1M Buy
66,417
+9,635
+17% +$1.92M 0.16% 136
2014
Q3
$10.1M Sell
56,782
-2,384
-4% -$396K 0.13% 147
2014
Q2
$10M Sell
59,166
-10,878
-16% -$1.69M 0.13% 143
2014
Q1
$8.69M Buy
70,044
+3,855
+6% +$469K 0.11% 156
2013
Q4
$7.35M Buy
66,189
+28,246
+74% +$2.7M 0.11% 177
2013
Q3
$3.43M Sell
37,943
-17,534
-32% -$1.57M 0.08% 201
2013
Q2
$4.67M Buy
+55,477
New +$5.76M 0.09% 199

Other funds holding AGN

ProShare Advisors's AGN Position: Q1 2015 in Review

ProShare Advisors sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 66,417 shares — an estimated $14.1M sold.

ProShare Advisors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $14.1M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • ProShare Advisors reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • ProShare Advisors sold 66,417 Allergan Inc shares in Q1 2015, an estimated $14.1M.
  • ProShare Advisors first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • ProShare Advisors's Allergan Inc position peaked at $14.1M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.